Synta Pharma (SNTA) Reports Q4 Miss

March 11, 2011 7:29 AM EST
Synta Pharmaceuticals Corp. (NASDAQ: SNTA) reported Q4 EPS of ($0.21), $0.03 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $4.04 million versus the consensus estimate of $5.89 million.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings